Tumor necrosis factor-α and TNF-β inhibit clonogenicity of mobilized human hematopoietic progenitors

Journal of Interferon and Cytokine Research

Volumn 20, Issue 5, 2000, Pages 507-510

  Skobin, Vladimir ^a   Jelkmann, Wolfgang ^b   Morschakova, Elena ^a   Pavlov, Anatole D ^a   Schlenke, Peter ^b  

^a Res Inst for Pediatric Hematology   (Russian Federation)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLONOGENESIS; COLONY FORMATION; CONTROLLED STUDY; GROWTH INHIBITION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LEUKAPHERESIS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL;

CELL CULTURE TECHNIQUES; COLONY-FORMING UNITS ASSAY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; LYMPHOTOXIN-ALPHA; NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034125053     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/10799900050023924     Document Type: Article

References (30)

1. 1. GRATWOHL, A., PASSWEG, J., BALDOMERO, H., and HERMANS, J. (1999). Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant. 24, 231-245.
2. + autologous transplant in relapsed follicular lymphoma. Hematol. Cell Ther. 39, 33-40.
3. 3. BASSAN, R., CORTELAZZO, S., RAMBALDI, A., CORNELLI, P., BORLERI, G., BELLAVITA, P., BIONDI, A., and BARBUI, T. (1995). Autologous PBSC transplant for late onset AML after mafosfamide-purged and TBI-containing autologous BMT. Bone Marrow Transplant. 15, 791-793.
4. 4. ATRA, A., and PINKERTON, R. (1996). Autologous stem cell transplantation in solid tumours of childhood. Ann. Med. 28, 159-164.
5. 5. SCIME, R., INDOVINA, A., SANTORO, A., MUSSO, M., OLIVIERI, A., TRINGALI, S., CRESCIMANNO, A., MONTANARI, M., FELICE, R., CATANIA, P., MARIANI, G., LEONI, P., and MAJOLINO, I. (1998). PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. Bone Marrow Transplant. 22, 1159-1165.
6. 6. CLUITMANS, F.H., ESENDAM, B.H., LANDEGENT, J.E., WILLEMZE, R., and FALKENBURG, J.H. (1995). Constituve in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood 85, 2038-2044.
7. + T cells and monocytes from growth factor-mobilized peripheral blood stem cell products: a mechanism of immune dysfunction. J. Interferon Cytokine Res. 19, 351-360.
8. 8. BROXMEYER, H.E., WILLIAMS, D.E., LU, L., COOPER, S., ANDERSON, S.L., BEYER, G.S., HOFFMAN, R., and RUBIN, B.Y. (1986). The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor nectosis factor and interferon-gamma. J. Immunol. 136, 4487-4495.
9. + cells. Bone Marrow Transplant. 22, 457-468.
10. + progenitors. Exp. Hematol. 23, 551-556.
11. 11. VOLKERS, B., GANSER, A., GREHER, J., STELLA, C.C., and HOELZER, D. (1989). Untersuchungen ueber die Wirkung von Tumornekrosefaktor auf humane haematopoetische Vorlauferzellen. Onkologie 12, 109-115.
12. 12. FERRAJOLI, A., TALPAZ, M., KURZROCK, R., and ESTROV, Z. (1993). Analysis of the effects of tumor necrosis factor inhibitors on human hematopoiesis. Stem Cells 11, 112-119.
13. 13. SELLERI, C., SATO, T., ANDERSON, S., YOUNG, N.S., and MACIEJEWSKI, J.P. (1995). Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death. J. Cell. Physiol. 165, 538-546.
14. 14. NAGAFUJI, K., SHIBUYA, T., HARADA, M. MIZUNO, S., TAKENAKA, K., MIYAMOTO, T., OKAMURA, T., GONDO, H., and NIHO, Y. (1995). Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells. Blood 86, 883-889.
15. 15. SNOECK, H.W., WEEKX, S., MOULIJN, A., LARDON, F., LENJOU, M., NYS, G., VAN-RANST, P.C., VAN-BOCK-STAELE, D.R., and BERNEMAN, Z.N. (1996). Tumor necrosis factor alpha is a potent synergistic factor for the proliferation of primitive human hematopoietic progenitor cells and induces resistance to transforming growth factor beta but not to interferon gamma. J. Exp. Med. 183, 705-710.
16. 16. PIACIBELLO, W., FERRERO, D., SANAVIO, P., BADONI, R., STACCHINI, A., SEVERINO, A., and AGLIETTA, M. (1991). Responsiveness of highly enriched CFU-GM subpopulations from bone marrow, peripheral blood, and cord blood to hemopoietic growth inhibitors. Exp. Hematol. 19, 1084-1089.
17. 17. RATAJCZAK, M.Z., and RATAJCZAK, J. (1994). In vitro studies of anemia accompanying a chronic inflammatory processes and neoplasms. Effect of cachectin (TNF-alpha) and lymphotoxin (TNF-beta) on human erythropoiesis. Pol. Tyg. Lek. 49, 280-283.
18. 18. BROWNING, J., and RIBOLINI, A. (1989). Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines. J. Immunol. 143, 1859-1867.
19. 19. ROODMAN, G.D., JONSON, R.A., and CLIBON, U. (1989). Tumor necrosis factor alpha and the anemia of chronic disease: effects of chronic exposure to TNF on erythropoiesis in vivo. Adv. Exp. Med. Biol. 271, 185-196.
20. 20. JELKMANN, W. (1998). Proinflammatory cytokines lowering erythropoietin production. J. Interferon Cytokine Res. 18, 555-559.
21. 21. JELKMANN, W. (1994). Biology of erythropoietin. Clin. Invest. 72 (Suppl. 6), 3-10.
22. 22. FANDREY, J., and JELKMANN, W.E. (1991). Interleukin-1 and tumor necrosis factor-alpha inhibit erythropoietin production in vitro. Ann. NY Acad. Sci. 628, 250-255.
23. 23. SKOBIN, V., PAVLOV, A., MORSCHAKOVA, E., and JELKMANN, W. (1998). TNF-beta inhibits EPO production in HepG2 cells. Hematol. Transfusiol. 43, 28-30.
24. 24. TRIOZZI, P.L., TUCKER, F., BENZIES, T., and BALCERZAK, S.P. (1996). Antitumor and accessory immune activities of peripheral blood stem cells mobilized with granulocyte-macrophage colony-stimulating factor. Bone Marrow Transplant. 18, 47-52.
25. 25. AREMAN, E.M., RHODES, P.L., MAZUMDER, A., and MEEHAN, K.R., (1999). Differential effects of IL-2 incubation on hematopoietic potential of autologous bone marrow and mobilized PBSC from patients with hematologic malignancies. J. Hematother. 8, 39-44.
26. 26. LEMOLI, R.M., VISANI, G., LEOPARDI, G., MOTTA, M.R., RIZZI, S., TESTONI, N., CURTI, A., and TURA, S. (1999). Autologous transplantation of chemocherapy-purged PBSC collections from high-risk leukemia patients: a pilot study. Bone Marrow Transplant. 23, 235-241.
27. 27. ROECKLEIN, B.A., REEMS, J., ROWLEY, S., and TOROKSTORB, B. (1998). Ex vivo expansion of immature 4-hydroheroxycyclophosphamide-resistant progenitor cells from G-CSF-mobilized peripheral blood. Biol. Blood Marrow Transplant. 4, 61-68.
28. 28. MOTTA, M.R., MANGIANTI, S., RIZZI, S., RATTA, M., CAMPANINI, E., FORTUNA, A., FOGLI, M., TURA, S., and LEMOLI, R.M. (1997). Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies. Exp. Hematol. 25, 1261-1269.
29. 29. DREXLER, H.G., ZABORSKI, M., and QUENTMEIER, H. (1997). Cytokine response profiles of human myeloid factor-dependent leukemia cell lines. Leukemia 11, 701-708.
30. 30. CARTER, A., HADDAD, N., DRAXLER, I., ISRAELI, E., RAZ, B., and ROWE, J.M. (1996). Expression and role in growth regulation of tumour necrosis factor receptors p55 and p75 in acute myeloblastic leukaemia cells. Br. J. Haematol. 92, 116-126.